DTG/3TC demonstrated non-inferior efficacy to BIC/FTC/TAF, with favorable weight gain outcomes in certain subgroups. Fostemsavir showed efficacy in maintaining viral suppression and CD4 recovery ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈